Aveanna Healthcare (NASDAQ:AVAH) Sets New 1-Year High – Here’s What Happened

by · The Cerbat Gem

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Get Free Report)’s stock price reached a new 52-week high during trading on Friday . The stock traded as high as $5.99 and last traded at $5.87, with a volume of 202219 shares changing hands. The stock had previously closed at $5.59.

Wall Street Analyst Weigh In

AVAH has been the subject of several analyst reports. UBS Group boosted their price objective on Aveanna Healthcare from $1.70 to $2.80 and gave the company a “sell” rating in a report on Friday, August 9th. Royal Bank of Canada boosted their price target on Aveanna Healthcare from $3.00 to $5.00 and gave the company a “sector perform” rating in a report on Friday, August 9th. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on shares of Aveanna Healthcare from $3.00 to $5.00 and gave the company a “buy” rating in a report on Friday, August 9th.

Check Out Our Latest Stock Analysis on Aveanna Healthcare

Aveanna Healthcare Stock Up 4.3 %

The company has a market cap of $1.13 billion, a PE ratio of -8.83 and a beta of 2.13. The business has a 50-day simple moving average of $5.13 and a 200-day simple moving average of $3.94.

Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last issued its quarterly earnings results on Thursday, August 8th. The company reported ($0.01) EPS for the quarter, topping the consensus estimate of ($0.04) by $0.03. The company had revenue of $504.96 million during the quarter, compared to analysts’ expectations of $494.02 million. On average, research analysts forecast that Aveanna Healthcare Holdings Inc. will post -0.09 EPS for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of AVAH. Littlejohn & Co. LLC increased its stake in Aveanna Healthcare by 7.4% during the 1st quarter. Littlejohn & Co. LLC now owns 8,377,258 shares of the company’s stock worth $20,859,000 after buying an additional 578,488 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Aveanna Healthcare during the third quarter worth approximately $817,000. Renaissance Technologies LLC raised its stake in Aveanna Healthcare by 155.8% in the 2nd quarter. Renaissance Technologies LLC now owns 158,600 shares of the company’s stock valued at $438,000 after purchasing an additional 96,600 shares during the last quarter. Acadian Asset Management LLC lifted its holdings in Aveanna Healthcare by 176.6% in the 2nd quarter. Acadian Asset Management LLC now owns 81,275 shares of the company’s stock valued at $222,000 after purchasing an additional 51,890 shares in the last quarter. Finally, Vanguard Group Inc. boosted its stake in Aveanna Healthcare by 1.8% during the 1st quarter. Vanguard Group Inc. now owns 2,571,251 shares of the company’s stock worth $6,402,000 after purchasing an additional 44,970 shares during the last quarter. Institutional investors and hedge funds own 87.96% of the company’s stock.

About Aveanna Healthcare

(Get Free Report)

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.

Recommended Stories